Rezolute RZLT
NASDAQ RZLT
$3.88 -0.19 (-4.67%)
As of: Nov 12, 2026 · 10:23 AM EST

Rezolute (RZLT) Gains (Losses) on Sale of Assets & Investments (2018 - 2026)

Updated

Rezolute (RZLT) reported Gains (Losses) on Sale of Assets & Investments of -$12,000 for FY2019 (year ended Jun 30, 2019), compared with -$663,000 in FY2018.

Analysis

Rezolute (RZLT) Gains (Losses) on Sale of Assets & Investments (2018 - 2026) Analysis & Trends

  • According to Business Quant data, Gains (Losses) on Sale of Assets & Investments came in at -$663,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rezolute 388.82 Mn -62.24 Mn - -53,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -53,000.00
Jun 30, 2026 -4,000.00
Mar 31, 2026 -162,000.00
Dec 31, 2025 -2,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 -50,000.00
Mar 31, 2025 -21,000.00
Dec 31, 2024 -225,000.00
Sep 30, 2024 368,000.00
Jun 30, 2024 -1,000.00
Mar 31, 2024 -30,000.00
Dec 31, 2023 236,000.00
Sep 30, 2023 67,000.00
Jun 30, 2023 -219,000.00
Mar 31, 2023 -132,000.00
Mar 31, 2019 11,000.00
Dec 31, 2018 -46,000.00
Sep 30, 2018 23,000.00
API Access

Rezolute Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RZLT&period=max&api_key=YOUR_API_KEY